In an era of convergence, the current growth trajectory across the microbiome industry englobes all verticals, from pharmaceutical and diagnostics to cosmetic and nutrition. Some of the milestones that have occurred in the microbiome field include the application of next-generation screening toward identifying and assessing microbial levels within the human gut. Using these microbial biomarkers, scientists are pushing the boundaries by identifying novel drug targets as well as probiotic or prebiotic products that could aid in balancing the microbial ecosystem within the human body.
“The Microbiome is coming of age. Microbial systems have largely been viewed as targets for disease prevention. Now that there is a recognition of the impact that microbial systems can have in promoting health, preventing a wide variety of disease and educating the immune system, the market is buzzing.” Sudeep Basu
The webinar will provide expert insight on why investors think of the Microbiome as a hot portfolio segment and why there is such a rapid convergence of players in the field from across industry verticals. Come and surf this wave with Dr. Basu!
Key benefits of attending the briefing:
- Listen to experts and discover what is novel about microbiome technologies, and why they are important for the future of the pharmaceutical, nutrition, diagnostics, cosmetics and other aligned industries.
- Learn which are some of the interesting companies/organizations involved in developing Microbiome products.
- Gain insight into the microbiome industry, how many products are available commercially, and how does the pipeline look for continued market growth.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion
For more information, visit ww2.frost.com or call +1 (877) 463-7678.
Frost & Sullivan
+1 (210) 348.1012
SOURCE Frost & Sullivan
Powered by WPeMatico